Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ras GTPase-Activating Proteins | 2 | 2018 | 101 | 1.160 |
Why?
|
| Melanoma | 5 | 2020 | 5510 | 0.600 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 196 | 0.590 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2020 | 625 | 0.540 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.500 |
Why?
|
| ras Proteins | 1 | 2018 | 1060 | 0.450 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2017 | 1285 | 0.430 |
Why?
|
| GTP Phosphohydrolases | 2 | 2020 | 509 | 0.290 |
Why?
|
| Peptides | 1 | 2017 | 4409 | 0.260 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2022 | 170 | 0.240 |
Why?
|
| Skin Neoplasms | 3 | 2020 | 5686 | 0.230 |
Why?
|
| Receptors, Androgen | 3 | 2022 | 1058 | 0.200 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 13695 | 0.190 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2020 | 2043 | 0.170 |
Why?
|
| F-Box Proteins | 1 | 2019 | 197 | 0.160 |
Why?
|
| Nuclear Localization Signals | 1 | 2017 | 80 | 0.150 |
Why?
|
| Mutation | 5 | 2021 | 29786 | 0.150 |
Why?
|
| Cell Line, Tumor | 8 | 2023 | 16689 | 0.150 |
Why?
|
| Drug Synergism | 2 | 2018 | 1792 | 0.140 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 594 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 1270 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 1526 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2020 | 7880 | 0.110 |
Why?
|
| Neoplasms | 2 | 2019 | 21683 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 944 | 0.110 |
Why?
|
| Protein Transport | 1 | 2017 | 1988 | 0.100 |
Why?
|
| Osteosarcoma | 1 | 2015 | 881 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2942 | 0.080 |
Why?
|
| Prostatic Neoplasms | 2 | 2021 | 11124 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5172 | 0.080 |
Why?
|
| Pyrimidinones | 2 | 2020 | 371 | 0.080 |
Why?
|
| Cell Survival | 1 | 2017 | 5882 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.070 |
Why?
|
| Genome, Human | 1 | 2019 | 4420 | 0.070 |
Why?
|
| Cell Movement | 1 | 2017 | 5217 | 0.070 |
Why?
|
| Pyridones | 2 | 2020 | 712 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5256 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8428 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 6364 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2529 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 1 | 2022 | 21 | 0.050 |
Why?
|
| Survival Rate | 1 | 2015 | 12788 | 0.050 |
Why?
|
| Animals | 5 | 2021 | 168757 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 250 | 0.050 |
Why?
|
| Humans | 12 | 2023 | 744343 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2020 | 337 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3752 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2019 | 261 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2020 | 708 | 0.040 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 162 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 648 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 675 | 0.030 |
Why?
|
| Epigenomics | 1 | 2021 | 903 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 29063 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 5535 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2540 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2022 | 2969 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2018 | 1959 | 0.030 |
Why?
|
| RNA Interference | 1 | 2021 | 2889 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 2948 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2020 | 3748 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1878 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1655 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3462 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2015 | 2716 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 4554 | 0.020 |
Why?
|
| Base Sequence | 1 | 2019 | 12797 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9386 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3444 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4215 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4204 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2849 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 4851 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 13284 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2015 | 3023 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
| Models, Biological | 1 | 2019 | 9583 | 0.010 |
Why?
|
| Male | 4 | 2022 | 350118 | 0.010 |
Why?
|
| Mice | 2 | 2018 | 81183 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2020 | 23403 | 0.010 |
Why?
|
Concepts
(82)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_